Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Metabolon patents

Patents where

Current Assignee

Name

Metabolon

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11536726 Mass spectrometry assay method for detection and quantitation of liver function metabolites	Patent 11536726 was granted and assigned to Metabolon on December, 2022 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	11536726	December 27, 2022
‌ US Patent 10267777 Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment	Patent 10267777 was granted and assigned to Metabolon on April, 2019 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	10267777	April 23, 2019
‌ US Patent 7884318 Systems, methods, and computer-readable medium for determining composition of chemical constituents in a complex mixture	Patent 7884318 was granted and assigned to Metabolon on February, 2011 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7884318	February 8, 2011
‌ US Patent 11387087 Method for analyzing small molecule components of a complex mixture, and associated apparatus and computer program product	Patent 11387087 was granted and assigned to Metabolon on July, 2022 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	11387087	July 12, 2022
‌ US Patent 11619636 Mass spectrometry assay method for detection and quantitation of kidney function metabolites	Patent 11619636 was granted and assigned to Metabolon on April, 2023 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	11619636	April 4, 2023
‌ US Patent 7561975 System, method, and computer program product for analyzing spectrometry data to identify and quantify individual components in a sample	Patent 7561975 was granted and assigned to Metabolon on July, 2009 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7561975	July 14, 2009
‌ US Patent 8187830 Method for determining insulin sensitivity with biomarkers	Patent 8187830 was granted and assigned to Metabolon on May, 2012 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	8187830	May 29, 2012
‌ US Patent 11527306 Streamlined method for analytical validation of biochemicals detected using an untargeted mass-spectrometry platform	Patent 11527306 was granted and assigned to Metabolon on December, 2022 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	11527306	December 13, 2022
‌ US Patent 7781160 Biomarkers related to metabolic age and methods using the same	Patent 7781160 was granted and assigned to Metabolon on August, 2010 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7781160	August 24, 2010
‌ US Patent 7005255 Methods for drug discovery, disease treatment, and diagnosis using metabolomics	Patent 7005255 was granted and assigned to Metabolon on February, 2006 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7005255	February 28, 2006
‌ US Patent 9250225 Biomarkers for insulin resistance and methods using the same	Patent 9250225 was granted and assigned to Metabolon on February, 2016 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	9250225	February 2, 2016
‌ US Patent 10890592 Automated sample quality assessment	Patent 10890592 was granted and assigned to Metabolon on January, 2021 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	10890592	January 12, 2021
‌ US Patent 10175233 Biomarkers for cardiovascular diseases and methods using the same	Patent 10175233 was granted and assigned to Metabolon on January, 2019 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	10175233	January 8, 2019
‌ US Patent 10502729 Diagnostic methods, therapeutic agents and uses thereof	Patent 10502729 was granted and assigned to Metabolon on December, 2019 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	10502729	December 10, 2019
‌ US Patent 8131473 Data analysis methods for locating entities of interest within large, multivariable datasets	Patent 8131473 was granted and assigned to Metabolon on March, 2012 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	8131473	March 6, 2012
‌ US Patent 11181530 Mass spectrometry method for detection and quantitation of metabolites	Patent 11181530 was granted and assigned to Metabolon on November, 2021 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	11181530	November 23, 2021
‌ US Patent 10539575 Biomarkers related to kidney function and methods using the same	Patent 10539575 was granted and assigned to Metabolon on January, 2020 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	10539575	January 21, 2020
‌ US Patent 9910047 Biomarkers related to insulin resistance progression and methods using the same	Patent 9910047 was granted and assigned to Metabolon on March, 2018 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	9910047	March 6, 2018
‌ US Patent 7949475 System and method for analyzing metabolomic data	Patent 7949475 was granted and assigned to Metabolon on May, 2011 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7949475	May 24, 2011
‌ US Patent 10573406 Method, apparatus and computer program product for metabolomics analysis	Patent 10573406 was granted and assigned to Metabolon on February, 2020 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	10573406	February 25, 2020
‌ US Patent 7807138 Biomarkers of metabolic responses to hepatic drugs	Patent 7807138 was granted and assigned to Metabolon on October, 2010 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7807138	October 5, 2010
‌ US Patent 8849577 Methods of identifying biochemical pathways	Patent 8849577 was granted and assigned to Metabolon on September, 2014 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	8849577	September 30, 2014
‌ US Patent 10302663 Method of assessing pancreatic beta-cell function	Patent 10302663 was granted and assigned to Metabolon on May, 2019 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	10302663	May 28, 2019
‌ US Patent 11061005 Mass spectrometry assay method for detection and quantitation of organic acid metabolites	Patent 11061005 was granted and assigned to Metabolon on July, 2021 by the United States Patent and Trademark Office.	Metabolon	Metabolon	United States Patent and Trademark Office	11061005	July 13, 2021
‌ US Patent 7433787 System, method, and computer program product using a database in a computing system to compile and compare metabolomic data obtained from a plurality of samples	Patent 7433787 was granted and assigned to Metabolon on October, 2008 by the United States Patent and Trademark Office.		Metabolon	United States Patent and Trademark Office	7433787	October 7, 2008

Results per page:

36 results

0 selected

36 results

0 selected